Nuclera awarded £1.14M Innovate UK funding for development of eProtein Discovery
£790k FASST grant, in collaboration with DeepMirror, and £350k Engineering Biology grant awarded for platform development.
MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK
New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours
Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
SAN DIEGO - PRNewswire -- Illumina Inc., a global leader in DNA sequencing and array-based technologies, announces it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments.
o2h Group heralds massive demand for Cambridge Wide Open Day
Attendance levels for the 2024 Cambridge Wide Open Day on Wednesday June 12 are already double the numbers at last year’s inaugural event. o2h Group, which is organising the event, has persuaded some world-class life science and technology companies plus relevant associated organisations to open their doors to visitors.
VALANX Biotech announces promising results in first in-vivo study of novel protein conjugate therapy
Study demonstrates pre-clinical efficacy of lead program VLX101 in treating autoimmune disease
CYPG is recruiting!
Would you like to become a committee member?
Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows
Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells
Living with paediatric asthma
A number of different management techniques can help in controlling asthma in children. The aim of these management techniques is to enable the child to have a “normal life”, free of asthma symptoms.
Precision in every layer: celebrating over two decades of 3D printing innovation at IPFL
In the fast-evolving world of 3D printing, staying ahead of the curve means not only keeping pace with current trends but also pioneering new technologies. At IPFL (Industrial Plastic Fabrications Ltd), our unwavering commitment to innovation is evident in our rich history of over 55 years in bespoke plastic manufacturing and a remarkable 21-year journey in additive manufacturing.
Sable&Hawkes deliver campaign graphics and new product illustrations for global biotech
Sable&Hawkes have delivered product and marketing illustrations, icons and infographics for global biopharma and life sciences company Sartorius.
Mursla Bio presents breakthrough liquid biopsy technology for extracellular vesicles in Cell Press
Novel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press’ iScience.
SolasCure selected for Innovate UK Global Incubator Programme in Houston
Programme delivered in partnership with the Texas Medical Centre Programme will support Aurase Wound Gel for future entry into US market, advancing SolasC
PhoreMost achieves second milestone in target discovery alliance with Boehringer Ingelheim
Milestone payment follows successful target identification and validation in separate project under same collaboration
DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation
Cambridge and Newcastle UK: DefiniGEN Ltd., and Atelerix Ltd., announces they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US.
Accelerate@Babraham selects its next set of science superstars!
Cambridge - Six life science start-ups looking to develop products and services to make a positive difference to healthcare have been selected for one of Europe’s top incubators based at the
Time from EMA approval to CT outcome for first indication vs. AMSR
This post launches a series of infographics focused on pricing and market access trends of rare disease treatments in France.
How ‘The Face Doctors’ help patients face the world
The incredible skills of an Addenbrooke’s prosthetist and three clinicians come into focus in the fourth episode of ‘The Face Doctors’ on Really at 9pm on Wednesday (5 June), also available to stream on discovery+.
Nxera Pharma and PrecisionLife expand strategic R&D partnership into new therapeutic area
Tokyo, Japan, Oxford and Cambridge, UK - Nxera Pharma Co. Ltd and PrecisionLife, the Causal AI precision medicine company, announces the expansion of their strategic R&D partnership into auto-immune disorders with the potential to identify new drug targets for the treatment of complex, chronic conditions.
H.E.L Group extends sales and support with appointment of specialist distributors
Distributors will provide added application specific support for H.E.L’s biotechnology and chemical synthesis product portfolios in the USA, Spain and Portugal.
Impact of medicare price “negotiation” program on small and large molecule medicines
The Inflation Reduction Act (IRA) directs the U.S. federal government to set a “Maximum Fair Price” (MFP) for the medicines with the highest spending in Medicare.
Skylight Psychiatry joins Salus Wellness
Salus Wellness are happy to announce that Skylight Psychiatry has joined Salus Wellness this month. Skylight Psychiatry is a CQC regulated specialist multidisciplinary service for Adults. They support autistic people, people with Neurodevelopmental Disorders (ADHD, Learning Disabilities, Down Syndrome and others) and the Neurodiverse population who do not have a diagnosis and are in need of…
Bailey Fisher raises £10,000 for Break at Annual Charity Golf Day
Bailey Fisher welcomed 80 golfers from businesses around the region for the executive search firm's annual charity golf day, raising over £10,000 for Break, to help make a difference to the lives of vulnerable young people.
Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing
Partnership to develop and implement Cellular Origins’ robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult’s Stevenage Manufacturing Innovation Centre
SPT Labtech and Watchmaker Genomics partner to simplify and streamline NGS library preparation
Automated protocols now available for mRNA and DNA sequencing.
Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics
Partnership expands spectrum of Secarna’s capabilities for the development of targeted ASOs beyond antibodies and sugar molecules